UK & International Health Policy and Drug Safety
Chair: Prof Penny Ward
The ‘UK & International Health Policy and Drug Safety’ group considers government and regulatory consultations, legislation, bills and white papers etc. related to all aspects of healthcare where pharmaceutical R&D, regulatory affairs and medical affairs are impacted. The group’s remit covers all aspects of pharmaceutical medicine – from clinical pharmacology, through phase 1-4 clinical trials, regulatory interactions, to post-licensing monitoring, and drug safety and pharmacovigilance.
The group may also comment on developments in closely related fields, such as the prescribing of medicines, pharmacy, and education and training on the development and use of medicines for all healthcare professionals. The primary focus of the group is on UK legislation, but it also considers global developments and important legislation from key markets around the world.
